These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Common pitfalls when using the Liver Imaging Reporting and Data System (LI-RADS): lessons learned from a multi-year experience. Cannella R; Fowler KJ; Borhani AA; Minervini MI; Heller M; Furlan A Abdom Radiol (NY); 2019 Jan; 44(1):43-53. PubMed ID: 30073400 [TBL] [Abstract][Full Text] [Related]
3. Imaging after local tumor therapies: kidney and liver. Kielar AZ; Hibbert RM; Maturen KE Semin Roentgenol; 2013 Jul; 48(3):273-84. PubMed ID: 23796378 [No Abstract] [Full Text] [Related]
4. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules. Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F; J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247 [TBL] [Abstract][Full Text] [Related]
5. Contrast harmonic sonographically guided radio frequency ablation for spontaneous ruptured hepatocellular carcinoma. Tamai H; Oka M; Maeda H; Shingaki N; Kanno T; Enomoto S; Shiraki T; Iguchi M; Nakazawa K; Arii K; Yanaoka K; Shimizu Y; Nakata H; Fujishiro M; Yahagi N; Shiina S; Ichinose M J Ultrasound Med; 2005 Jul; 24(7):1021-6. PubMed ID: 15972719 [No Abstract] [Full Text] [Related]
6. Evaluation of hemodynamic imaging findings of hypervascular hepatocellular carcinoma: comparison between dynamic contrast-enhanced magnetic resonance imaging using radial volumetric imaging breath-hold examination with k-space-weighted image contrast reconstruction and dynamic computed tomography during hepatic arteriography. Kurozumi M; Fujinaga Y; Kitou Y; Yamada A; Ohya A; Adachi Y; Tsukahara Y; Nickel MD; Maruyama K; Uehara T; Miyagawa SI; Kadoya M Jpn J Radiol; 2018 Apr; 36(4):295-302. PubMed ID: 29327116 [TBL] [Abstract][Full Text] [Related]
7. CEUS and HCC: are the 2008 EFSUMB guidelines still valid or has their wash-out already started? Giorgio A; Calisti G; Giorgio V Ultraschall Med; 2011 Jun; 32(3):315-6. PubMed ID: 21667409 [No Abstract] [Full Text] [Related]
8. Recommendation for terminology: Nodules without arterial phase hyperenhancement and with hepatobiliary phase hypointensity in chronic liver disease. Motosugi U; Murakami T; Lee JM; Fowler KJ; Heiken JP; Sirlin CB; J Magn Reson Imaging; 2018 Nov; 48(5):1169-1171. PubMed ID: 30347132 [TBL] [Abstract][Full Text] [Related]
10. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI. Kitao A; Matsui O; Yoneda N; Kita R; Kozaka K; Kobayashi S; Gabata T AJR Am J Roentgenol; 2018 Aug; 211(2):347-357. PubMed ID: 29708786 [TBL] [Abstract][Full Text] [Related]
11. Hepatocellular Carcinoma Screening at Transplant Centers: Counterpoint-CT and MRI Are the Way to Go. Olson MC; Venkatesh SK AJR Am J Roentgenol; 2021 Mar; 216(3):581-582. PubMed ID: 32812801 [No Abstract] [Full Text] [Related]
12. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Choi JY; Lee JM; Sirlin CB Radiology; 2014 Oct; 273(1):30-50. PubMed ID: 25247563 [TBL] [Abstract][Full Text] [Related]
13. Contrast-Enhanced Ultrasound of Focal Liver Lesions. Chaubal N; Joshi M; Bam A; Chaubal R Semin Roentgenol; 2016 Oct; 51(4):334-357. PubMed ID: 27743569 [No Abstract] [Full Text] [Related]
14. LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents. Santillan C; Fowler K; Kono Y; Chernyak V Abdom Radiol (NY); 2018 Jan; 43(1):75-81. PubMed ID: 28828680 [TBL] [Abstract][Full Text] [Related]
15. Hepatocellular Carcinoma Assessment after Locoregional Treatment: A Primer on LI-RADS Contrast-Enhanced Nonradiation Treatment Response Assessment Version 2024. Milot L Radiology; 2024 May; 311(2):e240124. PubMed ID: 38805731 [No Abstract] [Full Text] [Related]
16. Will CT take second billing to MR imaging for the diagnosis of hypervascular hepatocellular carcinomas hereafter? Kanematsu M Radiology; 2011 Aug; 260(2):607; author reply 607-8. PubMed ID: 21778455 [No Abstract] [Full Text] [Related]
17. Contrast-enhanced computed tomography plus gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging for gross classification of hepatocellular carcinoma. Chen C; Zhao H; Fu X; Huang L; Tang M; Yan X; Sun S; Jia W; Mao L; Shi J; Chen J; He J; Zhu J; Qiu Y Oncotarget; 2017 May; 8(18):29741-29750. PubMed ID: 28392502 [TBL] [Abstract][Full Text] [Related]